Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Kehl

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|December 22, 2018
Race, Poverty, and Initial Implementation of Precision Medicine for Lung CancerKenneth L Kehl, Christopher S Lathan, Bruce E Johnson, et al.
Biometrics|May 21, 2024
Regression models for average hazardHajime Uno, Lu Tian, Miki Horiguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care ActKenneth L Kehl, Kai-Ping Liao, Trudy M Krause, et al.
Breast Cancer Research and Treatment|December 27, 2015
Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
JAMA Network Open|May 21, 2021
Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung CancerKenneth L Kehl, Scott Greenwald, Nassib G Chamoun, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 27, 2026
Harnessing Artificial Intelligence for the Management of Patients With GI CancersLipika Goyal, Caroline Chung, Yuichi Mori, et al.
Psycho-Oncology|August 26, 2020
Patient and proxy reports regarding the experience of treatment decision-making in cancer careJessica K Roydhouse, Roee Gutman, Ira B Wilson, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancerKenneth L Kehl, Shihao Yang, Mark M Awad, et al.
NPJ Digital Medicine|June 10, 2025
Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from electronic health recordsIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Noman Ashraf, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|December 22, 2018
Race, Poverty, and Initial Implementation of Precision Medicine for Lung CancerKenneth L Kehl, Christopher S Lathan, Bruce E Johnson, et al.
Biometrics|May 21, 2024
Regression models for average hazardHajime Uno, Lu Tian, Miki Horiguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care ActKenneth L Kehl, Kai-Ping Liao, Trudy M Krause, et al.
Breast Cancer Research and Treatment|December 27, 2015
Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
JAMA Network Open|May 21, 2021
Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung CancerKenneth L Kehl, Scott Greenwald, Nassib G Chamoun, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 27, 2026
Harnessing Artificial Intelligence for the Management of Patients With GI CancersLipika Goyal, Caroline Chung, Yuichi Mori, et al.
Psycho-Oncology|August 26, 2020
Patient and proxy reports regarding the experience of treatment decision-making in cancer careJessica K Roydhouse, Roee Gutman, Ira B Wilson, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancerKenneth L Kehl, Shihao Yang, Mark M Awad, et al.
NPJ Digital Medicine|June 10, 2025
Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from electronic health recordsIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Noman Ashraf, et al.
Pageof 8